Author Question: Can information life-span be a determining factor in deciding which organization structure is ... (Read 63 times)

jrubin

  • Hero Member
  • *****
  • Posts: 552
Can information life-span be a determining factor in deciding which organization structure is superior?

Question 2

A unique resource can serve as
 A) an economic profit
  B) a sunk cost
  C) an entry barrier
  D) none of these choices



stallen

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

The type of organization structure which may be suitable for a particular firm can depend on information life-span. If information is durable and applies to all or most of a firm's activities a U-form firm with centralized decisions may be better able to access knowledge that has accumulated over time and is still valuable. If information has a short lifespan and is specialized to particular products or areas, an M-form firm that leaves more decisions to divisional managers is superior.

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

When blood is exposed to air, it clots. Heparin allows the blood to come in direct contact with air without clotting.

Did you know?

Cyanide works by making the human body unable to use oxygen.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Adults are resistant to the bacterium that causes Botulism. These bacteria thrive in honey – therefore, honey should never be given to infants since their immune systems are not yet resistant.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library